These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3320536)
21. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors. Adams DJ; McGuire WL Cancer Res; 1985 Jun; 45(6):2445-9. PubMed ID: 3886134 [TBL] [Abstract][Full Text] [Related]
22. The use of fine-needle aspirates of breast cancers to evaluate hormone-receptor status. Lundy J; Lozowski M; Sadri D; Mishriki Y Arch Surg; 1990 Feb; 125(2):174-6. PubMed ID: 2302058 [TBL] [Abstract][Full Text] [Related]
23. Recognition with a monoclonal antibody of a cytoplasmic mammary carcinoma antigen, correlated to the estrogen receptor status. Krohn K; Helle M Int J Cancer; 1986 Jan; 37(1):43-7. PubMed ID: 3941021 [TBL] [Abstract][Full Text] [Related]
24. Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cano A; Coffer AI; Adatia R; Millis RR; Rubens RD; King RJ Cancer Res; 1986 Dec; 46(12 Pt 1):6475-80. PubMed ID: 3536082 [TBL] [Abstract][Full Text] [Related]
25. Immunodetection in fine-needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas. Charpin C; Andrac L; Habib MC; Vacheret H; Xerri L; Devictor B; Lavaut MN; Toga M Cancer; 1989 Mar; 63(5):863-72. PubMed ID: 2644015 [TBL] [Abstract][Full Text] [Related]
26. [Progesterone receptors in breast cancer]. Vitola GIa; Zeĭkate GA; Grabovska IK Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754 [TBL] [Abstract][Full Text] [Related]
27. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673 [TBL] [Abstract][Full Text] [Related]
28. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer. Hendler FJ; Yuan D Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148 [TBL] [Abstract][Full Text] [Related]
29. Improved measurement of androgen receptors in human breast cancer. Lea OA; Kvinnsland S; Thorsen T Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000. Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034 [TBL] [Abstract][Full Text] [Related]
31. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
32. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery]. Seifert M; Wierrani F; Kubista E; Spona J Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992 [No Abstract] [Full Text] [Related]
33. Correlation of estrogen, progesterone, and androgen receptors in breast cancer. Ellis LM; Wittliff JL; Bryant MS; Hogancamp WE; Sitren HS; Bland KI Am J Surg; 1989 Jun; 157(6):577-80; discussion 581. PubMed ID: 2499206 [TBL] [Abstract][Full Text] [Related]
34. Hormone receptors and Japanese breast cancer. Matsumoto K; Kitamura Y; Sugano H Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994 [TBL] [Abstract][Full Text] [Related]
35. Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Sica G; Natoli V; Stella C; Del Bianco S Cancer; 1987 Nov; 60(10):2419-23. PubMed ID: 3664427 [TBL] [Abstract][Full Text] [Related]
36. [Estrogen receptors of the human breast]. El'tsina NV Vopr Onkol; 1978; 24(8):108-15. PubMed ID: 358579 [No Abstract] [Full Text] [Related]
37. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403 [TBL] [Abstract][Full Text] [Related]
38. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Press MF; Xu SH; Wang JD; Greene GL Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797 [TBL] [Abstract][Full Text] [Related]
39. Steroid receptor analyses of nine human breast cancer cell lines. Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841 [TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections]. Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]